nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—ALB—melanoma	0.317	1	CbGaD
Clonazepam—ALB—Vemurafenib—melanoma	0.154	0.359	CbGbCtD
Clonazepam—CYP2E1—Dacarbazine—melanoma	0.122	0.285	CbGbCtD
Clonazepam—CYP3A4—Temozolomide—melanoma	0.0882	0.205	CbGbCtD
Clonazepam—CYP3A4—Vemurafenib—melanoma	0.0483	0.112	CbGbCtD
Clonazepam—CYP3A4—Docetaxel—melanoma	0.0166	0.0386	CbGbCtD
Clonazepam—Niclosamide—STAT3—melanoma	0.00433	0.819	CrCbGaD
Clonazepam—TSPO—hindlimb—melanoma	0.00232	0.174	CbGeAlD
Clonazepam—TSPO—appendage—melanoma	0.00199	0.149	CbGeAlD
Clonazepam—TSPO—hair follicle—melanoma	0.00118	0.0887	CbGeAlD
Clonazepam—GABRA3—neck—melanoma	0.00115	0.0863	CbGeAlD
Clonazepam—TSPO—blood vessel—melanoma	0.00111	0.0832	CbGeAlD
Clonazepam—TSPO—neck—melanoma	0.000794	0.0595	CbGeAlD
Clonazepam—TSPO—eye—melanoma	0.00059	0.0443	CbGeAlD
Clonazepam—TSPO—retina—melanoma	0.000585	0.0439	CbGeAlD
Clonazepam—TSPO—skin of body—melanoma	0.000514	0.0385	CbGeAlD
Clonazepam—Hypoaesthesia—Temozolomide—melanoma	0.000492	0.00229	CcSEcCtD
Clonazepam—Pharyngitis—Temozolomide—melanoma	0.000491	0.00229	CcSEcCtD
Clonazepam—Chills—Dactinomycin—melanoma	0.00049	0.00229	CcSEcCtD
Clonazepam—Urinary tract disorder—Temozolomide—melanoma	0.000488	0.00228	CcSEcCtD
Clonazepam—Oedema peripheral—Temozolomide—melanoma	0.000487	0.00227	CcSEcCtD
Clonazepam—Cardiac failure—Docetaxel—melanoma	0.000487	0.00227	CcSEcCtD
Clonazepam—Pruritus—Vemurafenib—melanoma	0.000486	0.00227	CcSEcCtD
Clonazepam—GABRA3—head—melanoma	0.000486	0.0365	CbGeAlD
Clonazepam—Connective tissue disorder—Temozolomide—melanoma	0.000486	0.00227	CcSEcCtD
Clonazepam—Lethargy—Docetaxel—melanoma	0.000485	0.00226	CcSEcCtD
Clonazepam—Urethral disorder—Temozolomide—melanoma	0.000484	0.00226	CcSEcCtD
Clonazepam—Alopecia—Dactinomycin—melanoma	0.000483	0.00225	CcSEcCtD
Clonazepam—Eye disorder—Carmustine—melanoma	0.000478	0.00223	CcSEcCtD
Clonazepam—Visual impairment—Temozolomide—melanoma	0.000476	0.00222	CcSEcCtD
Clonazepam—Flushing—Carmustine—melanoma	0.000475	0.00222	CcSEcCtD
Clonazepam—Ill-defined disorder—Bleomycin—melanoma	0.000473	0.00221	CcSEcCtD
Clonazepam—Anaemia—Bleomycin—melanoma	0.000471	0.0022	CcSEcCtD
Clonazepam—Diarrhoea—Vemurafenib—melanoma	0.00047	0.00219	CcSEcCtD
Clonazepam—TSPO—mammalian vulva—melanoma	0.000468	0.0351	CbGeAlD
Clonazepam—Migraine—Docetaxel—melanoma	0.000468	0.00218	CcSEcCtD
Clonazepam—Eye disorder—Temozolomide—melanoma	0.000462	0.00216	CcSEcCtD
Clonazepam—Malaise—Bleomycin—melanoma	0.00046	0.00215	CcSEcCtD
Clonazepam—Flushing—Temozolomide—melanoma	0.000459	0.00214	CcSEcCtD
Clonazepam—Cardiac disorder—Temozolomide—melanoma	0.000459	0.00214	CcSEcCtD
Clonazepam—Leukopenia—Bleomycin—melanoma	0.000457	0.00213	CcSEcCtD
Clonazepam—Dizziness—Vemurafenib—melanoma	0.000454	0.00212	CcSEcCtD
Clonazepam—Alopecia—Carmustine—melanoma	0.000452	0.00211	CcSEcCtD
Clonazepam—Mental disorder—Carmustine—melanoma	0.000448	0.00209	CcSEcCtD
Clonazepam—Ataxia—Docetaxel—melanoma	0.000447	0.00208	CcSEcCtD
Clonazepam—Immune system disorder—Temozolomide—melanoma	0.000446	0.00208	CcSEcCtD
Clonazepam—Malnutrition—Carmustine—melanoma	0.000445	0.00208	CcSEcCtD
Clonazepam—Cough—Bleomycin—melanoma	0.000445	0.00208	CcSEcCtD
Clonazepam—Chills—Temozolomide—melanoma	0.000443	0.00207	CcSEcCtD
Clonazepam—Dehydration—Docetaxel—melanoma	0.000442	0.00206	CcSEcCtD
Clonazepam—Ill-defined disorder—Dactinomycin—melanoma	0.000441	0.00206	CcSEcCtD
Clonazepam—Anaemia—Dactinomycin—melanoma	0.00044	0.00205	CcSEcCtD
Clonazepam—Liver function test abnormal—Docetaxel—melanoma	0.000439	0.00205	CcSEcCtD
Clonazepam—Vomiting—Vemurafenib—melanoma	0.000437	0.00204	CcSEcCtD
Clonazepam—Alopecia—Temozolomide—melanoma	0.000437	0.00204	CcSEcCtD
Clonazepam—Myalgia—Bleomycin—melanoma	0.000434	0.00203	CcSEcCtD
Clonazepam—Chest pain—Bleomycin—melanoma	0.000434	0.00203	CcSEcCtD
Clonazepam—Orthostatic hypotension—Docetaxel—melanoma	0.000434	0.00203	CcSEcCtD
Clonazepam—Rash—Vemurafenib—melanoma	0.000433	0.00202	CcSEcCtD
Clonazepam—Mental disorder—Temozolomide—melanoma	0.000433	0.00202	CcSEcCtD
Clonazepam—Dermatitis—Vemurafenib—melanoma	0.000433	0.00202	CcSEcCtD
Clonazepam—Back pain—Carmustine—melanoma	0.000431	0.00201	CcSEcCtD
Clonazepam—Headache—Vemurafenib—melanoma	0.00043	0.00201	CcSEcCtD
Clonazepam—Malnutrition—Temozolomide—melanoma	0.00043	0.00201	CcSEcCtD
Clonazepam—Breast disorder—Docetaxel—melanoma	0.000429	0.002	CcSEcCtD
Clonazepam—Discomfort—Bleomycin—melanoma	0.000429	0.002	CcSEcCtD
Clonazepam—Malaise—Dactinomycin—melanoma	0.000429	0.002	CcSEcCtD
Clonazepam—Cramp muscle—Docetaxel—melanoma	0.000428	0.002	CcSEcCtD
Clonazepam—Leukopenia—Dactinomycin—melanoma	0.000426	0.00199	CcSEcCtD
Clonazepam—Nasopharyngitis—Docetaxel—melanoma	0.000425	0.00198	CcSEcCtD
Clonazepam—Confusional state—Bleomycin—melanoma	0.00042	0.00196	CcSEcCtD
Clonazepam—Vision blurred—Carmustine—melanoma	0.00042	0.00196	CcSEcCtD
Clonazepam—Tremor—Carmustine—melanoma	0.000417	0.00195	CcSEcCtD
Clonazepam—Anaphylactic shock—Bleomycin—melanoma	0.000416	0.00194	CcSEcCtD
Clonazepam—Oedema—Bleomycin—melanoma	0.000416	0.00194	CcSEcCtD
Clonazepam—Back pain—Temozolomide—melanoma	0.000416	0.00194	CcSEcCtD
Clonazepam—Infection—Bleomycin—melanoma	0.000414	0.00193	CcSEcCtD
Clonazepam—Anaemia—Carmustine—melanoma	0.000412	0.00192	CcSEcCtD
Clonazepam—Dysphagia—Docetaxel—melanoma	0.000411	0.00192	CcSEcCtD
Clonazepam—Agitation—Carmustine—melanoma	0.000409	0.00191	CcSEcCtD
Clonazepam—Nausea—Vemurafenib—melanoma	0.000408	0.0019	CcSEcCtD
Clonazepam—Thrombocytopenia—Bleomycin—melanoma	0.000408	0.0019	CcSEcCtD
Clonazepam—Vision blurred—Temozolomide—melanoma	0.000405	0.00189	CcSEcCtD
Clonazepam—Myalgia—Dactinomycin—melanoma	0.000405	0.00189	CcSEcCtD
Clonazepam—Tremor—Temozolomide—melanoma	0.000403	0.00188	CcSEcCtD
Clonazepam—Discomfort—Dactinomycin—melanoma	0.0004	0.00187	CcSEcCtD
Clonazepam—Ill-defined disorder—Temozolomide—melanoma	0.000399	0.00186	CcSEcCtD
Clonazepam—Leukopenia—Carmustine—melanoma	0.000399	0.00186	CcSEcCtD
Clonazepam—Anaemia—Temozolomide—melanoma	0.000398	0.00186	CcSEcCtD
Clonazepam—Anorexia—Bleomycin—melanoma	0.000397	0.00185	CcSEcCtD
Clonazepam—GABRG2—head—melanoma	0.000396	0.0297	CbGeAlD
Clonazepam—GABRB2—head—melanoma	0.000396	0.0297	CbGeAlD
Clonazepam—Agitation—Temozolomide—melanoma	0.000395	0.00185	CcSEcCtD
Clonazepam—Angioedema—Temozolomide—melanoma	0.000393	0.00183	CcSEcCtD
Clonazepam—Hypotension—Bleomycin—melanoma	0.000389	0.00182	CcSEcCtD
Clonazepam—Oedema—Dactinomycin—melanoma	0.000388	0.00181	CcSEcCtD
Clonazepam—Malaise—Temozolomide—melanoma	0.000388	0.00181	CcSEcCtD
Clonazepam—Vertigo—Temozolomide—melanoma	0.000387	0.0018	CcSEcCtD
Clonazepam—Infection—Dactinomycin—melanoma	0.000386	0.0018	CcSEcCtD
Clonazepam—Leukopenia—Temozolomide—melanoma	0.000385	0.0018	CcSEcCtD
Clonazepam—Palpitations—Temozolomide—melanoma	0.00038	0.00177	CcSEcCtD
Clonazepam—Thrombocytopenia—Dactinomycin—melanoma	0.00038	0.00177	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Bleomycin—melanoma	0.000379	0.00177	CcSEcCtD
Clonazepam—Myalgia—Carmustine—melanoma	0.000379	0.00177	CcSEcCtD
Clonazepam—Chest pain—Carmustine—melanoma	0.000379	0.00177	CcSEcCtD
Clonazepam—Anxiety—Carmustine—melanoma	0.000378	0.00176	CcSEcCtD
Clonazepam—Cough—Temozolomide—melanoma	0.000375	0.00175	CcSEcCtD
Clonazepam—Weight increased—Docetaxel—melanoma	0.000374	0.00174	CcSEcCtD
Clonazepam—Weight decreased—Docetaxel—melanoma	0.000372	0.00173	CcSEcCtD
Clonazepam—Dyspnoea—Bleomycin—melanoma	0.000371	0.00173	CcSEcCtD
Clonazepam—Anorexia—Dactinomycin—melanoma	0.00037	0.00173	CcSEcCtD
Clonazepam—Pneumonia—Docetaxel—melanoma	0.000368	0.00172	CcSEcCtD
Clonazepam—Confusional state—Carmustine—melanoma	0.000366	0.00171	CcSEcCtD
Clonazepam—Arthralgia—Temozolomide—melanoma	0.000366	0.00171	CcSEcCtD
Clonazepam—Myalgia—Temozolomide—melanoma	0.000366	0.00171	CcSEcCtD
Clonazepam—Anxiety—Temozolomide—melanoma	0.000365	0.0017	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000364	0.0017	CcSEcCtD
Clonazepam—Oedema—Carmustine—melanoma	0.000363	0.0017	CcSEcCtD
Clonazepam—Discomfort—Temozolomide—melanoma	0.000362	0.00169	CcSEcCtD
Clonazepam—Decreased appetite—Bleomycin—melanoma	0.000362	0.00169	CcSEcCtD
Clonazepam—Infection—Carmustine—melanoma	0.000361	0.00168	CcSEcCtD
Clonazepam—Neuropathy peripheral—Docetaxel—melanoma	0.000359	0.00167	CcSEcCtD
Clonazepam—Dry mouth—Temozolomide—melanoma	0.000358	0.00167	CcSEcCtD
Clonazepam—Pain—Bleomycin—melanoma	0.000356	0.00166	CcSEcCtD
Clonazepam—Thrombocytopenia—Carmustine—melanoma	0.000356	0.00166	CcSEcCtD
Clonazepam—Tachycardia—Carmustine—melanoma	0.000355	0.00165	CcSEcCtD
Clonazepam—Confusional state—Temozolomide—melanoma	0.000354	0.00165	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000354	0.00165	CcSEcCtD
Clonazepam—Anaphylactic shock—Temozolomide—melanoma	0.000351	0.00164	CcSEcCtD
Clonazepam—Oedema—Temozolomide—melanoma	0.000351	0.00164	CcSEcCtD
Clonazepam—GABRA1—head—melanoma	0.00035	0.0262	CbGeAlD
Clonazepam—Infection—Temozolomide—melanoma	0.000349	0.00163	CcSEcCtD
Clonazepam—Anorexia—Carmustine—melanoma	0.000346	0.00162	CcSEcCtD
Clonazepam—Epistaxis—Docetaxel—melanoma	0.000345	0.00161	CcSEcCtD
Clonazepam—Nervous system disorder—Temozolomide—melanoma	0.000344	0.00161	CcSEcCtD
Clonazepam—Thrombocytopenia—Temozolomide—melanoma	0.000344	0.0016	CcSEcCtD
Clonazepam—Feeling abnormal—Bleomycin—melanoma	0.000343	0.0016	CcSEcCtD
Clonazepam—Skin disorder—Temozolomide—melanoma	0.000341	0.00159	CcSEcCtD
Clonazepam—Hypotension—Carmustine—melanoma	0.00034	0.00158	CcSEcCtD
Clonazepam—Decreased appetite—Dactinomycin—melanoma	0.000337	0.00157	CcSEcCtD
Clonazepam—TSPO—head—melanoma	0.000335	0.0251	CbGeAlD
Clonazepam—Fatigue—Dactinomycin—melanoma	0.000335	0.00156	CcSEcCtD
Clonazepam—Anorexia—Temozolomide—melanoma	0.000335	0.00156	CcSEcCtD
Clonazepam—Pain—Dactinomycin—melanoma	0.000332	0.00155	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Carmustine—melanoma	0.000331	0.00154	CcSEcCtD
Clonazepam—Urticaria—Bleomycin—melanoma	0.000331	0.00154	CcSEcCtD
Clonazepam—Haemoglobin—Docetaxel—melanoma	0.00033	0.00154	CcSEcCtD
Clonazepam—Rhinitis—Docetaxel—melanoma	0.00033	0.00154	CcSEcCtD
Clonazepam—Body temperature increased—Bleomycin—melanoma	0.000329	0.00154	CcSEcCtD
Clonazepam—Haemorrhage—Docetaxel—melanoma	0.000329	0.00153	CcSEcCtD
Clonazepam—Insomnia—Carmustine—melanoma	0.000329	0.00153	CcSEcCtD
Clonazepam—Hypoaesthesia—Docetaxel—melanoma	0.000327	0.00153	CcSEcCtD
Clonazepam—Pharyngitis—Docetaxel—melanoma	0.000326	0.00152	CcSEcCtD
Clonazepam—Urinary tract disorder—Docetaxel—melanoma	0.000325	0.00151	CcSEcCtD
Clonazepam—Dyspnoea—Carmustine—melanoma	0.000324	0.00151	CcSEcCtD
Clonazepam—Oedema peripheral—Docetaxel—melanoma	0.000324	0.00151	CcSEcCtD
Clonazepam—Somnolence—Carmustine—melanoma	0.000323	0.00151	CcSEcCtD
Clonazepam—Connective tissue disorder—Docetaxel—melanoma	0.000323	0.00151	CcSEcCtD
Clonazepam—Urethral disorder—Docetaxel—melanoma	0.000322	0.0015	CcSEcCtD
Clonazepam—Feeling abnormal—Dactinomycin—melanoma	0.00032	0.00149	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Temozolomide—melanoma	0.00032	0.00149	CcSEcCtD
Clonazepam—Clozapine—CYP1B1—melanoma	0.000319	0.0603	CrCbGaD
Clonazepam—Insomnia—Temozolomide—melanoma	0.000318	0.00148	CcSEcCtD
Clonazepam—Gastrointestinal pain—Dactinomycin—melanoma	0.000317	0.00148	CcSEcCtD
Clonazepam—Visual impairment—Docetaxel—melanoma	0.000317	0.00148	CcSEcCtD
Clonazepam—Decreased appetite—Carmustine—melanoma	0.000316	0.00147	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Carmustine—melanoma	0.000314	0.00146	CcSEcCtD
Clonazepam—Dyspnoea—Temozolomide—melanoma	0.000313	0.00146	CcSEcCtD
Clonazepam—Somnolence—Temozolomide—melanoma	0.000312	0.00146	CcSEcCtD
Clonazepam—Constipation—Carmustine—melanoma	0.000311	0.00145	CcSEcCtD
Clonazepam—Pain—Carmustine—melanoma	0.000311	0.00145	CcSEcCtD
Clonazepam—Dyspepsia—Temozolomide—melanoma	0.000309	0.00144	CcSEcCtD
Clonazepam—Eye disorder—Docetaxel—melanoma	0.000307	0.00143	CcSEcCtD
Clonazepam—Body temperature increased—Dactinomycin—melanoma	0.000307	0.00143	CcSEcCtD
Clonazepam—Abdominal pain—Dactinomycin—melanoma	0.000307	0.00143	CcSEcCtD
Clonazepam—Hypersensitivity—Bleomycin—melanoma	0.000307	0.00143	CcSEcCtD
Clonazepam—Decreased appetite—Temozolomide—melanoma	0.000305	0.00142	CcSEcCtD
Clonazepam—Flushing—Docetaxel—melanoma	0.000305	0.00142	CcSEcCtD
Clonazepam—Cardiac disorder—Docetaxel—melanoma	0.000305	0.00142	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Temozolomide—melanoma	0.000303	0.00141	CcSEcCtD
Clonazepam—Fatigue—Temozolomide—melanoma	0.000303	0.00141	CcSEcCtD
Clonazepam—Pain—Temozolomide—melanoma	0.0003	0.0014	CcSEcCtD
Clonazepam—Constipation—Temozolomide—melanoma	0.0003	0.0014	CcSEcCtD
Clonazepam—Feeling abnormal—Carmustine—melanoma	0.000299	0.0014	CcSEcCtD
Clonazepam—Asthenia—Bleomycin—melanoma	0.000299	0.00139	CcSEcCtD
Clonazepam—Gastrointestinal pain—Carmustine—melanoma	0.000297	0.00139	CcSEcCtD
Clonazepam—Immune system disorder—Docetaxel—melanoma	0.000297	0.00139	CcSEcCtD
Clonazepam—Chills—Docetaxel—melanoma	0.000295	0.00138	CcSEcCtD
Clonazepam—Pruritus—Bleomycin—melanoma	0.000295	0.00137	CcSEcCtD
Clonazepam—Alopecia—Docetaxel—melanoma	0.00029	0.00136	CcSEcCtD
Clonazepam—Feeling abnormal—Temozolomide—melanoma	0.000289	0.00135	CcSEcCtD
Clonazepam—Mental disorder—Docetaxel—melanoma	0.000288	0.00134	CcSEcCtD
Clonazepam—Body temperature increased—Carmustine—melanoma	0.000287	0.00134	CcSEcCtD
Clonazepam—Abdominal pain—Carmustine—melanoma	0.000287	0.00134	CcSEcCtD
Clonazepam—Gastrointestinal pain—Temozolomide—melanoma	0.000287	0.00134	CcSEcCtD
Clonazepam—Malnutrition—Docetaxel—melanoma	0.000286	0.00134	CcSEcCtD
Clonazepam—Hypersensitivity—Dactinomycin—melanoma	0.000286	0.00133	CcSEcCtD
Clonazepam—Urticaria—Temozolomide—melanoma	0.000279	0.0013	CcSEcCtD
Clonazepam—Asthenia—Dactinomycin—melanoma	0.000279	0.0013	CcSEcCtD
Clonazepam—Body temperature increased—Temozolomide—melanoma	0.000278	0.0013	CcSEcCtD
Clonazepam—Abdominal pain—Temozolomide—melanoma	0.000278	0.0013	CcSEcCtD
Clonazepam—Back pain—Docetaxel—melanoma	0.000277	0.00129	CcSEcCtD
Clonazepam—Muscle spasms—Docetaxel—melanoma	0.000275	0.00128	CcSEcCtD
Clonazepam—Hypersensitivity—Carmustine—melanoma	0.000268	0.00125	CcSEcCtD
Clonazepam—Diarrhoea—Dactinomycin—melanoma	0.000266	0.00124	CcSEcCtD
Clonazepam—Vomiting—Bleomycin—melanoma	0.000265	0.00124	CcSEcCtD
Clonazepam—Anaemia—Docetaxel—melanoma	0.000264	0.00123	CcSEcCtD
Clonazepam—Rash—Bleomycin—melanoma	0.000262	0.00122	CcSEcCtD
Clonazepam—Dermatitis—Bleomycin—melanoma	0.000262	0.00122	CcSEcCtD
Clonazepam—Asthenia—Carmustine—melanoma	0.000261	0.00122	CcSEcCtD
Clonazepam—Hypersensitivity—Temozolomide—melanoma	0.000259	0.00121	CcSEcCtD
Clonazepam—Leukopenia—Docetaxel—melanoma	0.000256	0.0012	CcSEcCtD
Clonazepam—Palpitations—Docetaxel—melanoma	0.000253	0.00118	CcSEcCtD
Clonazepam—Asthenia—Temozolomide—melanoma	0.000252	0.00118	CcSEcCtD
Clonazepam—Cough—Docetaxel—melanoma	0.00025	0.00117	CcSEcCtD
Clonazepam—Diarrhoea—Carmustine—melanoma	0.000249	0.00116	CcSEcCtD
Clonazepam—Pruritus—Temozolomide—melanoma	0.000248	0.00116	CcSEcCtD
Clonazepam—Nausea—Bleomycin—melanoma	0.000247	0.00115	CcSEcCtD
Clonazepam—Vomiting—Dactinomycin—melanoma	0.000247	0.00115	CcSEcCtD
Clonazepam—Rash—Dactinomycin—melanoma	0.000245	0.00114	CcSEcCtD
Clonazepam—Chest pain—Docetaxel—melanoma	0.000244	0.00114	CcSEcCtD
Clonazepam—Arthralgia—Docetaxel—melanoma	0.000244	0.00114	CcSEcCtD
Clonazepam—Myalgia—Docetaxel—melanoma	0.000244	0.00114	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000242	0.00113	CcSEcCtD
Clonazepam—Dizziness—Carmustine—melanoma	0.00024	0.00112	CcSEcCtD
Clonazepam—Diarrhoea—Temozolomide—melanoma	0.00024	0.00112	CcSEcCtD
Clonazepam—Dry mouth—Docetaxel—melanoma	0.000238	0.00111	CcSEcCtD
Clonazepam—Confusional state—Docetaxel—melanoma	0.000235	0.0011	CcSEcCtD
Clonazepam—TSPO—lymph node—melanoma	0.000235	0.0176	CbGeAlD
Clonazepam—Anaphylactic shock—Docetaxel—melanoma	0.000234	0.00109	CcSEcCtD
Clonazepam—Oedema—Docetaxel—melanoma	0.000234	0.00109	CcSEcCtD
Clonazepam—Dizziness—Temozolomide—melanoma	0.000232	0.00108	CcSEcCtD
Clonazepam—Infection—Docetaxel—melanoma	0.000232	0.00108	CcSEcCtD
Clonazepam—Vomiting—Carmustine—melanoma	0.000231	0.00108	CcSEcCtD
Clonazepam—Nausea—Dactinomycin—melanoma	0.000231	0.00108	CcSEcCtD
Clonazepam—ALB—lymph node—melanoma	0.000229	0.0172	CbGeAlD
Clonazepam—Rash—Carmustine—melanoma	0.000229	0.00107	CcSEcCtD
Clonazepam—Nervous system disorder—Docetaxel—melanoma	0.000229	0.00107	CcSEcCtD
Clonazepam—Dermatitis—Carmustine—melanoma	0.000229	0.00107	CcSEcCtD
Clonazepam—Thrombocytopenia—Docetaxel—melanoma	0.000229	0.00107	CcSEcCtD
Clonazepam—Tachycardia—Docetaxel—melanoma	0.000228	0.00106	CcSEcCtD
Clonazepam—Headache—Carmustine—melanoma	0.000228	0.00106	CcSEcCtD
Clonazepam—Skin disorder—Docetaxel—melanoma	0.000227	0.00106	CcSEcCtD
Clonazepam—Vomiting—Temozolomide—melanoma	0.000223	0.00104	CcSEcCtD
Clonazepam—Anorexia—Docetaxel—melanoma	0.000223	0.00104	CcSEcCtD
Clonazepam—Rash—Temozolomide—melanoma	0.000221	0.00103	CcSEcCtD
Clonazepam—Dermatitis—Temozolomide—melanoma	0.000221	0.00103	CcSEcCtD
Clonazepam—Headache—Temozolomide—melanoma	0.00022	0.00103	CcSEcCtD
Clonazepam—Hypotension—Docetaxel—melanoma	0.000218	0.00102	CcSEcCtD
Clonazepam—Nausea—Carmustine—melanoma	0.000216	0.00101	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Docetaxel—melanoma	0.000213	0.000993	CcSEcCtD
Clonazepam—Insomnia—Docetaxel—melanoma	0.000211	0.000986	CcSEcCtD
Clonazepam—Nausea—Temozolomide—melanoma	0.000209	0.000973	CcSEcCtD
Clonazepam—Dyspnoea—Docetaxel—melanoma	0.000208	0.000972	CcSEcCtD
Clonazepam—Somnolence—Docetaxel—melanoma	0.000208	0.000969	CcSEcCtD
Clonazepam—Dyspepsia—Docetaxel—melanoma	0.000206	0.000959	CcSEcCtD
Clonazepam—Decreased appetite—Docetaxel—melanoma	0.000203	0.000947	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Docetaxel—melanoma	0.000202	0.000941	CcSEcCtD
Clonazepam—Fatigue—Docetaxel—melanoma	0.000201	0.00094	CcSEcCtD
Clonazepam—Pain—Docetaxel—melanoma	0.0002	0.000932	CcSEcCtD
Clonazepam—Constipation—Docetaxel—melanoma	0.0002	0.000932	CcSEcCtD
Clonazepam—CYP2E1—head—melanoma	0.000194	0.0145	CbGeAlD
Clonazepam—Feeling abnormal—Docetaxel—melanoma	0.000192	0.000898	CcSEcCtD
Clonazepam—Gastrointestinal pain—Docetaxel—melanoma	0.000191	0.000891	CcSEcCtD
Clonazepam—Abdominal pain—Docetaxel—melanoma	0.000185	0.000861	CcSEcCtD
Clonazepam—Body temperature increased—Docetaxel—melanoma	0.000185	0.000861	CcSEcCtD
Clonazepam—Hypersensitivity—Docetaxel—melanoma	0.000172	0.000803	CcSEcCtD
Clonazepam—Asthenia—Docetaxel—melanoma	0.000168	0.000782	CcSEcCtD
Clonazepam—Pruritus—Docetaxel—melanoma	0.000165	0.000771	CcSEcCtD
Clonazepam—Diarrhoea—Docetaxel—melanoma	0.00016	0.000746	CcSEcCtD
Clonazepam—Dizziness—Docetaxel—melanoma	0.000154	0.000721	CcSEcCtD
Clonazepam—Vomiting—Docetaxel—melanoma	0.000148	0.000693	CcSEcCtD
Clonazepam—Rash—Docetaxel—melanoma	0.000147	0.000687	CcSEcCtD
Clonazepam—Dermatitis—Docetaxel—melanoma	0.000147	0.000686	CcSEcCtD
Clonazepam—Headache—Docetaxel—melanoma	0.000146	0.000683	CcSEcCtD
Clonazepam—Nausea—Docetaxel—melanoma	0.000139	0.000647	CcSEcCtD
Clonazepam—Nitrazepam—ABCB1—melanoma	0.000131	0.0248	CrCbGaD
Clonazepam—Flurazepam—ABCB1—melanoma	0.000117	0.0221	CrCbGaD
Clonazepam—Midazolam—ABCB1—melanoma	0.000108	0.0205	CrCbGaD
Clonazepam—Diazepam—ALB—melanoma	9.71e-05	0.0184	CrCbGaD
Clonazepam—Diazepam—ABCB1—melanoma	9.27e-05	0.0175	CrCbGaD
Clonazepam—Clozapine—ABCB1—melanoma	9.15e-05	0.0173	CrCbGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CUBN—melanoma	2.36e-05	0.00112	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—FLNA—melanoma	2.35e-05	0.00112	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	2.35e-05	0.00112	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—NFKB1—melanoma	2.3e-05	0.0011	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—MDM2—melanoma	2.26e-05	0.00108	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—MDM2—melanoma	2.26e-05	0.00107	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PRKCA—melanoma	2.22e-05	0.00106	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—UGT2B10—melanoma	2.21e-05	0.00105	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.21e-05	0.00105	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ERCC2—melanoma	2.2e-05	0.00105	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—MDM2—melanoma	2.16e-05	0.00103	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.15e-05	0.00102	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CLU—melanoma	2.13e-05	0.00101	CbGpPWpGaD
Clonazepam—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	2.1e-05	0.001	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—melanoma	2.09e-05	0.000996	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—NFKB1—melanoma	2.08e-05	0.000993	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RHOB—melanoma	2.08e-05	0.000992	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ACER3—melanoma	2.08e-05	0.00099	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—BRAF—melanoma	2.06e-05	0.000983	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—MDM2—melanoma	2.06e-05	0.000983	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	2.06e-05	0.000981	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HS3ST5—melanoma	2.06e-05	0.000979	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	2.05e-05	0.000977	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—melanoma	2.05e-05	0.000976	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—VEGFA—melanoma	2.04e-05	0.000973	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TNF—melanoma	2.04e-05	0.000972	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—HGF—melanoma	2.04e-05	0.000971	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL6—melanoma	2.02e-05	0.000964	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—CSF2—melanoma	2.02e-05	0.000961	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP17A1—melanoma	2e-05	0.000952	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—MDM2—melanoma	1.98e-05	0.000942	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	1.97e-05	0.000939	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	1.97e-05	0.000936	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—melanoma	1.95e-05	0.000931	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—melanoma	1.94e-05	0.000927	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—ITGB3—melanoma	1.93e-05	0.000921	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PRKCA—melanoma	1.93e-05	0.000921	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—melanoma	1.93e-05	0.000919	CbGpPWpGaD
Clonazepam—ALB—Metabolism—UGT2B10—melanoma	1.9e-05	0.000905	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	1.88e-05	0.000898	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.88e-05	0.000894	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	1.87e-05	0.000892	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RAC2—melanoma	1.87e-05	0.000889	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—melanoma	1.84e-05	0.000877	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VEGFC—melanoma	1.84e-05	0.000875	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—melanoma	1.8e-05	0.000857	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—RAC1—melanoma	1.79e-05	0.000854	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	1.79e-05	0.000853	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HS3ST5—melanoma	1.77e-05	0.000842	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	1.76e-05	0.000841	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CG—melanoma	1.74e-05	0.000827	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—MDM2—melanoma	1.73e-05	0.000824	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP1B1—melanoma	1.68e-05	0.000802	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PPARG—melanoma	1.68e-05	0.000799	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	1.66e-05	0.000791	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	1.65e-05	0.000785	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL6—melanoma	1.65e-05	0.000785	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	1.64e-05	0.00078	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—TNF—melanoma	1.62e-05	0.000772	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SPARC—melanoma	1.61e-05	0.000768	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—F2R—melanoma	1.61e-05	0.000768	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—FN1—melanoma	1.58e-05	0.000754	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PLCB4—melanoma	1.56e-05	0.000742	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	1.55e-05	0.000738	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	1.54e-05	0.000735	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CD—melanoma	1.53e-05	0.000727	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CG—melanoma	1.51e-05	0.000721	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HSPA5—melanoma	1.51e-05	0.000719	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ALB—melanoma	1.51e-05	0.000718	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—EGF—melanoma	1.5e-05	0.000713	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—MAPK1—melanoma	1.48e-05	0.000704	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—HRAS—melanoma	1.48e-05	0.000704	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GAB2—melanoma	1.48e-05	0.000703	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GNA11—melanoma	1.48e-05	0.000703	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC6A11—melanoma	1.46e-05	0.000698	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIP4K2A—melanoma	1.46e-05	0.000698	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	1.45e-05	0.000689	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MTAP—melanoma	1.42e-05	0.000679	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.42e-05	0.000677	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	1.42e-05	0.000675	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—MAPK1—melanoma	1.41e-05	0.000672	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HDAC2—melanoma	1.39e-05	0.000661	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	1.39e-05	0.00066	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GNAQ—melanoma	1.37e-05	0.000653	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ITGA4—melanoma	1.37e-05	0.000653	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CD44—melanoma	1.37e-05	0.000653	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IFNB1—melanoma	1.36e-05	0.000649	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—MAPK1—melanoma	1.35e-05	0.000644	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PLCB4—melanoma	1.34e-05	0.000638	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	1.33e-05	0.000634	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CB—melanoma	1.33e-05	0.000634	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IFNA1—melanoma	1.33e-05	0.000633	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS2—melanoma	1.32e-05	0.000628	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	1.31e-05	0.000626	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL6—melanoma	1.31e-05	0.000623	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SYK—melanoma	1.29e-05	0.000614	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	1.28e-05	0.00061	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PHGDH—melanoma	1.27e-05	0.000605	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—LUM—melanoma	1.27e-05	0.000605	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ITGAV—melanoma	1.27e-05	0.000603	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—AKT3—melanoma	1.27e-05	0.000603	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC6A11—melanoma	1.26e-05	0.0006	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIP4K2A—melanoma	1.26e-05	0.0006	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HPSE—melanoma	1.25e-05	0.000593	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	1.24e-05	0.00059	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IFNA2—melanoma	1.24e-05	0.000589	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	1.23e-05	0.000586	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MTAP—melanoma	1.22e-05	0.000583	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CUBN—melanoma	1.22e-05	0.000582	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ALB—melanoma	1.22e-05	0.000582	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.2e-05	0.00057	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—HRAS—melanoma	1.19e-05	0.000565	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—MAPK1—melanoma	1.18e-05	0.000563	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SDHD—melanoma	1.18e-05	0.000563	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CSPG4—melanoma	1.18e-05	0.000563	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—BSG—melanoma	1.18e-05	0.000563	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	1.17e-05	0.000558	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	1.16e-05	0.000553	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTEN—melanoma	1.15e-05	0.000548	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ITGB1—melanoma	1.15e-05	0.000547	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GPAM—melanoma	1.14e-05	0.000545	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—HRAS—melanoma	1.13e-05	0.000539	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ACER3—melanoma	1.12e-05	0.000534	CbGpPWpGaD
Clonazepam—ALB—Metabolism—LUM—melanoma	1.09e-05	0.00052	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PHGDH—melanoma	1.09e-05	0.00052	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—HRAS—melanoma	1.09e-05	0.000517	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HPSE—melanoma	1.07e-05	0.00051	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	1.07e-05	0.000508	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HGF—melanoma	1.05e-05	0.000501	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CUBN—melanoma	1.05e-05	0.000501	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CSF2—melanoma	1.04e-05	0.000495	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—UGT2B10—melanoma	1.03e-05	0.000489	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	1.02e-05	0.000488	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SDHD—melanoma	1.01e-05	0.000483	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CSPG4—melanoma	1.01e-05	0.000483	CbGpPWpGaD
Clonazepam—ALB—Metabolism—BSG—melanoma	1.01e-05	0.000483	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ITGB3—melanoma	9.96e-06	0.000475	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PRKCA—melanoma	9.96e-06	0.000475	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GPAM—melanoma	9.83e-06	0.000468	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PLA2G6—melanoma	9.72e-06	0.000463	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HS3ST5—melanoma	9.54e-06	0.000454	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—HRAS—melanoma	9.49e-06	0.000452	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	9.37e-06	0.000447	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RAC1—melanoma	9.24e-06	0.00044	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	9.05e-06	0.000431	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MMP1—melanoma	8.94e-06	0.000426	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CDK2—melanoma	8.77e-06	0.000418	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—VCAN—melanoma	8.73e-06	0.000416	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	8.57e-06	0.000408	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PLA2G6—melanoma	8.36e-06	0.000398	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—FN1—melanoma	8.15e-06	0.000389	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	8.15e-06	0.000388	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CA—melanoma	8.11e-06	0.000387	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—NOS2—melanoma	8.06e-06	0.000384	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CG—melanoma	7.8e-06	0.000372	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—EGF—melanoma	7.71e-06	0.000368	CbGpPWpGaD
Clonazepam—ALB—Metabolism—VCAN—melanoma	7.51e-06	0.000358	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP17A1—melanoma	7.37e-06	0.000351	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PLCB4—melanoma	7.23e-06	0.000344	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IGF1—melanoma	7.15e-06	0.00034	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.1e-06	0.000339	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	7.07e-06	0.000337	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GNA11—melanoma	6.96e-06	0.000332	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CD—melanoma	6.86e-06	0.000327	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.86e-06	0.000327	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—FASN—melanoma	6.81e-06	0.000324	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC6A11—melanoma	6.8e-06	0.000324	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIP4K2A—melanoma	6.8e-06	0.000324	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC5A5—melanoma	6.7e-06	0.000319	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—AKT1—melanoma	6.63e-06	0.000316	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MTAP—melanoma	6.61e-06	0.000315	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GNAQ—melanoma	6.47e-06	0.000308	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CD44—melanoma	6.47e-06	0.000308	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP17A1—melanoma	6.33e-06	0.000302	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.25e-06	0.000298	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP1B1—melanoma	6.2e-06	0.000295	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GNA11—melanoma	5.98e-06	0.000285	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CB—melanoma	5.98e-06	0.000285	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—LUM—melanoma	5.89e-06	0.000281	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PHGDH—melanoma	5.89e-06	0.000281	CbGpPWpGaD
Clonazepam—ALB—Metabolism—FASN—melanoma	5.85e-06	0.000279	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HPSE—melanoma	5.78e-06	0.000275	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	5.78e-06	0.000275	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC5A5—melanoma	5.76e-06	0.000274	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CUBN—melanoma	5.67e-06	0.00027	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GNAQ—melanoma	5.56e-06	0.000265	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CD44—melanoma	5.56e-06	0.000265	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IL2—melanoma	5.49e-06	0.000262	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SDHD—melanoma	5.48e-06	0.000261	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—BSG—melanoma	5.48e-06	0.000261	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CSPG4—melanoma	5.48e-06	0.000261	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.44e-06	0.000259	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.39e-06	0.000257	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP1B1—melanoma	5.33e-06	0.000254	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GPAM—melanoma	5.31e-06	0.000253	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ABCB1—melanoma	5.11e-06	0.000243	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.7e-06	0.000224	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PRKCA—melanoma	4.7e-06	0.000224	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VEGFA—melanoma	4.67e-06	0.000222	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ERCC2—melanoma	4.66e-06	0.000222	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—NRAS—melanoma	4.61e-06	0.00022	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PLA2G6—melanoma	4.51e-06	0.000215	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MAPK3—melanoma	4.42e-06	0.00021	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ABCB1—melanoma	4.39e-06	0.000209	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MAPK1—melanoma	4.2e-06	0.0002	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—VCAN—melanoma	4.05e-06	0.000193	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PRKCA—melanoma	4.04e-06	0.000192	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ERCC2—melanoma	4.01e-06	0.000191	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—KRAS—melanoma	3.97e-06	0.000189	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CG—melanoma	3.68e-06	0.000175	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CA—melanoma	3.65e-06	0.000174	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PPARG—melanoma	3.55e-06	0.000169	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—melanoma	3.53e-06	0.000168	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP17A1—melanoma	3.42e-06	0.000163	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HRAS—melanoma	3.37e-06	0.000161	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.32e-06	0.000158	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CD—melanoma	3.24e-06	0.000154	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GNA11—melanoma	3.23e-06	0.000154	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALB—melanoma	3.2e-06	0.000152	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CG—melanoma	3.16e-06	0.000151	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—FASN—melanoma	3.16e-06	0.000151	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC5A5—melanoma	3.11e-06	0.000148	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PPARG—melanoma	3.05e-06	0.000145	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GNAQ—melanoma	3e-06	0.000143	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CD44—melanoma	3e-06	0.000143	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—AKT1—melanoma	2.98e-06	0.000142	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP1B1—melanoma	2.88e-06	0.000137	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CB—melanoma	2.82e-06	0.000134	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS2—melanoma	2.8e-06	0.000133	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CD—melanoma	2.78e-06	0.000133	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTEN—melanoma	2.44e-06	0.000116	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CB—melanoma	2.42e-06	0.000116	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS2—melanoma	2.4e-06	0.000114	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ABCB1—melanoma	2.37e-06	0.000113	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PRKCA—melanoma	2.18e-06	0.000104	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ERCC2—melanoma	2.16e-06	0.000103	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTEN—melanoma	2.1e-06	9.98e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CA—melanoma	1.72e-06	8.19e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CG—melanoma	1.71e-06	8.14e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PPARG—melanoma	1.65e-06	7.85e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CD—melanoma	1.5e-06	7.15e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALB—melanoma	1.48e-06	7.06e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CA—melanoma	1.48e-06	7.04e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—AKT1—melanoma	1.4e-06	6.69e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CB—melanoma	1.31e-06	6.24e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS2—melanoma	1.3e-06	6.18e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—AKT1—melanoma	1.21e-06	5.75e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTEN—melanoma	1.13e-06	5.39e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CA—melanoma	7.98e-07	3.8e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—AKT1—melanoma	6.52e-07	3.11e-05	CbGpPWpGaD
